Blog Posts

Dec 27, 2024, 10:54

Raul Cordoba: HIV association with tumor microenvironment immune reactivity in Hodgkin lymphoma

Raul Cordoba, Chair of Community Stakeholder Committee at European Hematology Association (EHA) and Coordinator of the Lymphoma Unit and Associate Chief of Hematology Department at Jiménez Díaz Foundation, shared a post on X:

“HIV infection is associated with compromised tumor microenvironment adaptive immune reactivity in Hodgkin lymphoma.”

HIV infection is associated with compromised tumor microenvironment adaptive immune reactivity in Hodgkin lymphoma

Authors: Amanda Chantziou et al.

Raul cordoba

Raúl Córdoba Mascuñano, MD, PhD is a specialist in hematology and hemotherapy. He is the Chair of Community Stakeholder Committee at European Hematology Association (EHA) and Coordinator of the Lymphoma Unit and Associate Chief of Hematology Department at Jiménez Díaz Foundation. He is the principal investigator for numerous clinical trials for non-Hodgkin lymphoma, Hodgkin lymphoma, chronic lymphocytic leukemia and other chronic lymphoproliferative syndromes. He is a member of the ethical review board at his current workplace.

Amanda Chantziou Anastasia Antoniadou cancer Cloe Brenna Constantinos Petrovas Kalliopi Ioannidou Laurence de Leval Maria Papaioannou Mina Psichogiou Oliver Y. Chen OncoDaily Oncology Panagiotis Tsirigotis Penelope Korkolopoulou Periklis G. Foukas Raul Cordoba

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer